Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SGMT
↓ PDF (Pro)Sagimet Biosciences Inc. Series A Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$7.99
+3.50%today
MKT CAP
$493M
+43.7% · 1Y
Earnings History
+18.5%
+35.5%
-2.2%
+27.8%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$7.99
Low
$8.00
Analyst Mean
$28.50
High
$49.00
10 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-5.2x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership3.3%
Institutional Ownership23.7%
Short % of Float12.10%
Days to Cover9.3d
1 Week-8.7%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MARTINS EDUARDO BRUNO | Officer | Stock | 44,000 | $0.00 | $0.00M | 2026-02-19 |
| CHAUCHE THIERRY | Chief Financial Officer | Stock | 44,000 | $0.00 | $0.00M | 2026-02-19 |
| ROZEK ELIZABETH | Officer | Stock | 44,000 | $0.00 | $0.00M | 2026-02-19 |
| HAPPEL DAVID | Chief Executive Officer | Stock | 128,000 | $0.00 | $0.00M | 2026-02-19 |
| MARTINS EDUARDO BRUNO | Officer | Sale | 3,640 | $5.36 | $0.02M | 2026-02-10 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Vanguard Group Inc | institution | 3.93% | $0.01B | +4.68% | 2025-12-31 |
| Blue Owl Capital Holdings LP | institution | 3.88% | $0.01B | -6.36% | 2025-12-31 |
| Affinity Asset Advisors, Llc | institution | 3.59% | $0.01B | +228.07% | 2025-12-31 |
| Woodline Partners LP | institution | 3.13% | $0.01B | -33.33% | 2025-12-31 |
| Baker Bros. Advisors, LP | institution | 2.98% | $0.01B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 2.54% | $0.01B | +32.84% | 2025-12-31 |
| Marshall Wace LLP | institution | 2.44% | $0.01B | +100.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.43% | $0.01B | +4.18% | 2025-12-31 |
| Siren, L.L.C. | institution | 2.26% | $0.01B | +0.00% | 2025-12-31 |
| HHLR Advisors, LTD | institution | 2.26% | $0.01B | +0.00% | 2025-12-31 |
| Millennium Management Llc | institution | 1.83% | $0.00B | -24.40% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.86% | $0.00B | +1.68% | 2025-12-31 |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | fund | 0.76% | $0.00B | +0.00% | 2025-12-31 |
| BlackRock Health Sciences Term Trust | fund | 0.69% | $0.00B | -7.46% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.59% | $0.00B | -4.18% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.44% | $0.00B | -0.02% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.23% | $0.00B | -21.33% | 2026-03-31 |
| American Century ETF Trust-Avantis U.S. Small Cap Equity ETF | fund | 0.18% | $0.00B | -0.31% | 2026-03-31 |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | fund | 0.17% | $0.00B | +100.00% | 2026-01-31 |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | fund | 0.15% | $0.00B | +0.00% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SGMT.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.